Our customers' Feedback
Search:
Perform search
Categories list

Generic Raloxifene - Evista

News & Dashboard
Search by letter:ABCDEFGHIJKLMNOPQRSTUVWXYZ
Evista
Generic Evista is used for treating and preventing osteoporosis (bone thinning) in women who are past menopause. It is also used to reduce the risk of invasive breast cancer in certain women who are past menopause.
$1.31
Social bookmarks:
Choose your language:
United Kingdom - EN/£France - FR/€Deutschland - DE/€España - ES/€Italia - IT/€Portugal - PT/€European Union - EN/€México - ES/$Brasil - PT/$Canada - FR/$




Money backguarantee
Secureshopping

Our billing is certified by:

Secure shopping certificates

Special Offer!

  • Lilly Wins Appeal on Validity of Evista Patent - Corporate Counsel

    Lilly Wins Appeal on Validity of Evista PatentCorporate CounselIn particular Teva pointed to work done by University of Pennsylvania scientist Alan Schreiber, who in 1991 got a patent on the use of raloxifene to treat .

  • Eli Lilly & Co. v. Teva Pharmaceuticals USA, Inc. (Fed. Cir. 2010) - Patent Docs (blog)

    Eli Lilly & Co.

  • ELI LILLY AND COMPANY v. TEVA PHARMACEUTICALS USA, INC. - Leagle.com

    Ha'aretzELI LILLY AND COMPANY v.

  • Report blacklists some preventive approaches - 6minutes

    TopNews United Kingdom (blog)Report blacklists some preventive approaches6minutes.

  • Too often, 'ghosts' are to blame for hiding scary news about hormone therapy ... - MinnPost.com (blog)

    Terra.

    Copyright © www.secure-pharm.com. All rights reserved.